Small molecule for infections
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
53
NCT04247542
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 6, 2020
Completion: Nov 15, 2023
Loading map...